N94.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Oth cond assoc w female genital organs and menstrual cycle. The 2019 edition of ICD-10-CM N94.89 became effective on October 1, 2018.
Oct 01, 2021 · Other specified conditions associated with female genital organs and menstrual cycle N94.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Oth cond assoc w female genital organs and …
Oct 01, 2021 · Irregular menstruation, unspecified. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. N92.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM N92.6 became …
Female Only. Code is only used for female patients. | ICD-10 from 2011 - 2016. N94.89 is a billable ICD code used to specify a diagnosis of other specified conditions associated with female genital organs and menstrual cycle. A 'billable code' is detailed enough to be used to specify a medical …
ICD-10-CM Diagnosis Code H53.34. Suppression of binocular vision. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. lactation O92.5. ICD-10-CM Diagnosis Code O92.5. …
A menstrual disorder is an abnormal condition in a woman's menstrual cycle.
DRG Group #742-743 - Uterine and adnexa procedure for non-malignancy with CC or MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code N94.89. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code N94.89 and a single ICD9 code, 629.89 is an approximate match for comparison and conversion purposes.
The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere.". Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code.
ICD 9 gives suppression of menstruation on to 626.8. I feel this holds good as for the reason for Suppression- therapeutic, induction, or any other reason not mentioned.#N#here it is for threraputic purpose of suppression for an adolescent CP; meaning, creating a disorder.#N#I think with this code and a secondary code for CP, along with physician report indicating why it is suppressed would go well.#N#Menstrual Regulation is evacuating the uterus for persons who have a short period of amenorrhea in early pregnancy.- a kind of an abortion procedure#N#By definition and stricly speaking, Menstrual regulation" (MR) or "menstrual extraction" (ME) are synonyms for an abortion procedure that is especially suited to circumventing the abortion laws of developing countries, because the abortions are performed so early that the "evidence" which results is either destroyed during the procedure or easily disposed of.#N#So it is not for suppressing the menstruation .#N#Secondly, it is not for "contraception" directly the supressing is undertaken for this girl; it for relieving her with all the ordeals she has to undergo with the menstrual process with the condition of CP though it could be one reason though. I fear whether we can admittedly and openly give this "contraception'' as the primary focus for suppressing or inducing amennorrhoeic status in her.#N#Does this explanation make some sense?
The Coding Clinic Third Quarter, 1997 says to assign code V25.02 (encounter for contraceptive management, initiation of other contraceptive measures) for the initial Depo-provera injection and code V25.49 (contraceptive management, other method) for subsequent follow-up visits.